[CITATION] Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-a Therapy: A Novel Cause of Noncicatricial Alopecia
LA Doyle, LC Sperling, S Baksh, J Lackey… - 2011 Related articles
W Valins, J Vega, S Amini… - Archives of …, 2011 - Am Med Assoc Background Alopecia areata is a common cause of hair loss seen in 3.8% of patients in dermatology clinics and in 0.2% to 2.0% of the general US population. The pathology of the disease remains poorly understood. Hair loss in alopecia areata can range from a single patch to 100% ...
JP Sundberg, KJ McElwee, JM Carroll… - Journal of Investigative …, 2011 - nature.com Rodent models with autoimmune diseases provide many insights to unravel the complexities of human diseases as tools for hypothesis testing and preclinical drug efficacy screening (Sun et al., 2008). Nearly 10 years ago, we performed a comparative mouse and human gene ...
SY Chu, YJ Chen, WC Tseng, MW Lin… - Journal of the …, 2011 - ncbi.nlm.nih.gov BACKGROUND: Alopecia areata (AA) is considered an autoimmune disease with undetermined pathogenesis. Age at onset predicts distinct outcomes. A nationwide study of the relationship of AA with associated diseases stratified by onset age has rarely been reported. ... All 2 versions
AM Finner - Dermatologic Therapy, 2011 - Wiley Online Library Alopecia areata (AA) is a nonscarring hair loss disorder with a 2% lifetime risk. Most patients are below 30 years old. Clinical types include patchy AA, AA reticularis, diffuse AA, AA ophiasis, AA sisiapho, and perinevoid AA. Besides scalp and body hair, the eyebrows, ... Related articles - All 2 versions